Table 1.
Demographics and drug use among current cigarette smokers in residential SUD treatment in California who report ever vs. never blunt/spliff use (N = 329).
| Mean (SD) or n (%) |
||||
|---|---|---|---|---|
| Total (N=329) | Smokers reporting ever blunt spliff use (n=197) | Smokers reporting never blunt spliff use (n=132) | p-value | |
| Demographics | ||||
| Age | 37.8 (11.4) | 34.0 (9.0) | 43.5 (12.1) | <0.0001 |
| Gender1 | 0.404 | |||
| Male | 242 (73.8%) | 150 (76.1%) | 92 (70.2%) | |
| Female | 81 (24.7%) | 44 (22.3%) | 37 (28.2%) | |
| Something else | 5 (1.5%) | 3 (1.5%) | 2 (1.5%) | 0.018 |
| Race/ethnicity | 0.018 | |||
| Hispanic/Latino | 111 (33.7%) | 67 (34.0%) | 44 (33.3%) | |
| African American | 58 (17.6%) | 25 (12.7%) | 33 (25.0%) | |
| Non- Hispanic White | 127 (38.6%) | 86 (43.7%) | 41 (31.1%) | |
| Other Education | 33 (10.0%) | 19 (9.6%) | 14 (10.6%) | 0.355 |
| <HS | 93 (28.3%) | 50 (25.4%) | 43 (32.6%) | |
| HS/GED | 117 (35.6%) | 72 (36.6%) | 45 (34.1%) | |
| >HS | 119 (36.2%) | 75 (38.1%) | 44 (33.3%) | 0.156 |
| Primary reason for treatment entry1 | ||||
| Alcohol | 51 (15.8%) | 28 (14.6%) | 23 (17.6%) | |
| Stimulant | 154 (47.7%) | 89 (46.4%) | 65 (49.6%) | |
| Marijuana/Cannabis | 11 (3.4%) | 7 (3.7%) | 4 (3.1%) | |
| Opioids | 70 (21.7%) | 50 (26.0%) | 20 (15.3%) | |
| Mental health or other | 37 (11.5%) | 18 (9.4%) | 19 (14.5%) | |
| Marijuana/cannabis as primary or secondary drug for treatment entry1,2 | 37 (12.7%) | 25 (14.0%) | 12 (10.6%) | 0.402 |
| Use of cannabis/THC in e-cigarettes/vape pens1 | 76 (23.4%) | 69 (35.2%) | 7 (5.4%) | <0.0001 |
1
Missing data: Gender (2), Primary drug for treatment entry (6), Marijuana/cannabis as primary or secondary drug for treatment entry (1), Use of cannabis/THC in e-cigarettes/vape pens (4).
2
Excluded 37 smokers whose reason for treatment entry was mental health or other.